Targeting angiogenesis in renal cell carcinoma

Author： Posadas Edwin M Limvorasak Suwicha Sharma Shaleekha Figlin Robert A

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.16, 2013-11, pp. : 2221-2236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Angiogenesis in Renal Cell Carcinoma

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 349-358

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review

Current Drug Targets, Vol. 18, Iss. 10, 2017-07 ,pp. : 1204-1213

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1058-1077

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain

By Castellano Daniel

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 455-463

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 11, 2015-11 ,pp. : 660-668

John Wiley & Sons Inc

Access to resources Recommend Favorite